학술논문
Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: A remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD)
Document Type
Article
Author
Source
In: Pediatric Blood and Cancer . (Pediatric Blood and Cancer, August 2011, 57(2):324-328)
Subject
Language
English
ISSN
15455009
15455017
15455017